Table 3.
Risk factors and comorbidity of individuals with serrated polyps according to Swedish histopathology reports
| Variable | HP | TSA | SSA/P | U | F | Total | |||
|---|---|---|---|---|---|---|---|---|---|
| SSA/P | SA | Mixed | Total | ||||||
| INDIVIDUALS | 34 (32%) | 3 (3%) | 8 (8%) | 51 (48%) | 12 (11%) | 70 (66%) | 3 (3%) | 5 (5%) | 106 (100%) |
| Smoking | |||||||||
| Current | 8 (24%) | 1 (33%) | 1 (13%) | 2 (4%) | 4 (33%) | 7 (10%) | 2 (67%) | 0 (0%) | 16 (15%) |
| Previous | 5 (15%) | 2 (67%) | 3 (38%) | 5 (10%) | 2 (17%) | 10 (14%) | 0 (0%) | 0 (0%) | 14 (13%) |
| BMI | |||||||||
| Obese* | 3 (9%) | 2 (67%) | 2 (25%) | 5 (10%) | 1 (8%) | 8 (11%) | 1 (33%) | 0 (0%) | 12 (11%) |
| Heredity | |||||||||
| CRC + § | 2 (6%) | 0 (0%) | 2 (25%) | 1 (2%) | 1 (8%) | 4 (6%) | 1 (33%) | 0 (0%) | 7 (7%) |
| Comorbidity | |||||||||
| Diverticulosis | 9 (26%) | 1 (33%) | 4 (50%) | 24 (47%) | 8 (67%) | 36 (51%) | 1 (33%) | 1 (20%) | 45 (42%) |
| CRC | 3 (9%) | 1 (33%) | 3 (38%) | 10 (20%) | 3 (25%) | 15 (21%) | 2 (67%) | 0 (0% | 19 (18%) |
| IBD | 4 (12%) | 0 (0%) | 0 (0%) | 5 (10%) | 1 (8%) | 6 (9%) | 0 (0%) | 0 (0%) | 10 (9%) |
Abbreviations: BMI = Body mass index; CRC = Colorectal cancer; F = False positive serrated polyp; HP = Hyperplastic polyp; IBD = Inflammatory bowel disease; SA = Serrated adenoma; SSA/P = Sessile serrated adenoma/polyp; TSA = Traditional serrated adenoma; U = Unspecified serrated polyp. *BMI ≥ 30 or indication of obesity in patient chart, §CRC and/or intestinal polyposis syndromes